HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
PDF Library
RSS Feeds
Subscribe
Advertising
Partnered Content
Report Store
UsernamePublicRestriction
Tags:

U.S. Bioscience Firm’s Anti-Inflammatory Compound Licensed In Japan

This article was originally published in The Rose Sheet

  • News

Executive Summary

A licensing deal between U.S. private biotech firm Signum Biosciences and Japanese skin care manufacturer Rohto Pharmaceutical will yield a range of anti-inflammatory skin care products in the Japanese market, the firms report Sept. 17

You may also be interested in...



Male Personal Care Up Worldwide, But American Men Hesitant About Makeup

The market for men's moisturizers and hair care is growing worldwide, as is demand for men's color cosmetics, though receptivity to such "advanced" male grooming products remains to an extent a culturally sensitive category, experts suggest

Aveda Offers Natural Solution To Hyperpigmentation With Embrightenment

Aveda introduces botanical-based Enbrightenment, a "multi-pronged" skin care regimen that adds luminosity while hydrating, soothing, exfoliating, evening skin tone and protecting against environmental aggressors

Tanda Light Energy For Battling Acne, Aging Is Available For Home Use

Pharos Life Corporation aims to secure a piece of the burgeoning home-use device market with its Tanda Clear anti-acne system, now available in the U.S. and Canada
Table

View full table

Tags:
UsernamePublicRestriction

Register

RS015681

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By